Literature DB >> 3596786

Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension.

T F Lüscher, P M Vanhoutte, L Raij.   

Abstract

Endothelium-dependent responses are impaired in various models of hypertension. The effects of antihypertensive treatment on endothelium-dependent relaxations were studied in Dahl salt-sensitive (DS) and Dahl salt-resistant rats (DR) on a high or low sodium diet. The rats were given either a diet containing 8% NaCl or 0.1% NaCl for 8 weeks or a diet containing 8% NaCl and a combination of reserpine, hydrochlorothiazide, and hydralazine for 8 or 2 weeks. DS on the 8% NaCl diet developed hypertension, while the other rats did not. Antihypertensive therapy for 8 or 2 weeks prevented or reversed hypertension in DS and lowered blood pressure in DR on the 8% NaCl diet. Aortic rings with and without endothelium were suspended in organ chambers for isometric tension recording. In all groups, acetylcholine, adenosine 5'-diphosphate, and thrombin caused endothelium-dependent relaxations. The relaxations in response to all agonists were significantly decreased in DS on 8% NaCl compared to relaxations in the other rats. Antihypertensive treatment for 8 or 2 weeks prevented or reversed the decreased endothelium-dependent relaxations in response to all agonists tested, but not those to the endothelium-independent agonist, sodium nitroprusside. These results suggest that antihypertensive treatment normalizes endothelium-dependent relaxations. This effect of antihypertensive treatment might be important for the prevention of cardiovascular complications in patients with hypertension.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3596786     DOI: 10.1161/01.hyp.9.6_pt_2.iii193

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

Review 1.  Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.

Authors:  Stefano Taddei; Agostino Virdis; Lorenzo Ghiadoni; Isabella Sudano; Antonio Salvetti
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Long-term blood pressure control: is there a set-point in the brain?

Authors:  Yasuhiro Nishida; Megumi Tandai-Hiruma; Takehito Kemuriyama; Kohsuke Hagisawa
Journal:  J Physiol Sci       Date:  2012-05       Impact factor: 2.781

3.  Role of the M3 muscarinic acetylcholine receptor subtype in murine ophthalmic arteries after endothelial removal.

Authors:  Adrian Gericke; Andreas Steege; Caroline Manicam; Tobias Böhmer; Jürgen Wess; Norbert Pfeiffer
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

Review 4.  Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance.

Authors:  G H Gibbons
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 5.  Role of microparticles in endothelial dysfunction and arterial hypertension.

Authors:  Thomas Helbing; Christoph Olivier; Christoph Bode; Martin Moser; Philipp Diehl
Journal:  World J Cardiol       Date:  2014-11-26

6.  Evidence for the presence of A(1) adenosine receptors in the aorta of spontaneously hypertensive rats.

Authors:  M Fahim; S J Mustafa
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 7.  Clinical relevance of endothelium-derived relaxing factor (EDRF).

Authors:  E Bassenge
Journal:  Br J Clin Pharmacol       Date:  1992       Impact factor: 4.335

8.  Blood pressure and impairment of endothelium-dependent relaxation in spontaneously hypertensive rats.

Authors:  S Sunano; S Osugi; K Shimamura
Journal:  Experientia       Date:  1989-08-15

Review 9.  The endothelial L-arginine/nitric oxide pathway and the renal circulation.

Authors:  T F Lüscher; H A Bock
Journal:  Klin Wochenschr       Date:  1991-09-03

10.  Effects of chloride substitution on electromechanical responses in the pulmonary artery of Dahl normotensive and hypertensive rats.

Authors:  Detlef Bieger; Jennifer A Duggan; Reza Tabrizchi
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.